Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
23.06
-0.43 (-1.83%)
At close: Aug 7, 2025, 4:00 PM
25.00
+1.94 (8.41%)
After-hours: Aug 7, 2025, 7:47 PM EDT
Nevro Revenue
Progyny had revenue of $332.87M in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to $1.24B, up 9.62% year-over-year. In the year 2024, Progyny had annual revenue of $1.17B with 7.22% growth.
Revenue (ttm)
$1.24B
Revenue Growth
+9.62%
P/S Ratio
1.61
Revenue / Employee
$1,826,424
Employees
680
Market Cap
1.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.17B | 78.62M | 7.22% |
Dec 31, 2023 | 1.09B | 301.69M | 38.34% |
Dec 31, 2022 | 786.91M | 286.29M | 57.19% |
Dec 31, 2021 | 500.62M | 155.76M | 45.17% |
Dec 31, 2020 | 344.86M | 115.18M | 50.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PGNY News
- 6 hours ago - Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 hours ago - Progyny, Inc. Announces Second Quarter 2025 Results - GlobeNewsWire
- 8 days ago - New Progyny Study Reveals Gap Between Perceptions and Realities in Women's Health Benefits Coverage - GlobeNewsWire
- 4 weeks ago - Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause - GlobeNewsWire
- 4 weeks ago - Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report - GlobeNewsWire
- 6 weeks ago - Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health - GlobeNewsWire
- 2 months ago - Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution - GlobeNewsWire
- 2 months ago - Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors - GlobeNewsWire